Thomas W Buford1, Michael E Miller2, Timothy S Church3, Thomas M Gill4, Rebecca Henderson5, Fang-Chi Hsu2, Mary M McDermott6, Neelesh Nadkarni7, Marco Pahor8, Randall S Stafford9, Christy S Carter8. 1. Department of Aging and Geriatric Research, College of Medicine, University of Florida, Gainesville. tbuford@ufl.edu. 2. Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina. 3. Preventive Medicine Laboratory, Pennington Biomedical Research Center, Baton Rouge, Louisiana. 4. Department of Internal Medicine, School of Medicine, Yale University, New Haven, Connecticut. 5. Section on Gerontology and Geriatrics, Wake Forest School of Medicine, Winston-Salem, North Carolina. 6. Department of Medicine and Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. 7. Department of Medicine, School of Medicine, University of Pittsburgh, Pennsylvania. 8. Department of Aging and Geriatric Research, College of Medicine, University of Florida, Gainesville. 9. Stanford Prevention Research Center, School of Medicine, Stanford University, Palo Alto, California.
Abstract
BACKGROUND: This subgroup analysis of the Lifestyle Intervention and Independence for Elders trial evaluates the impact of a long-term physical activity (PA) intervention on rates of major mobility disability (MMD) among older adults according to their antihypertensive medication use. METHODS: Lifestyle Intervention and Independence for Elders study participants were randomized to center-based PA or health education for a median of 2.7 years. Participants were sedentary men and women aged 70-89 years with objectively measured physical limitations. This analysis evaluated rates of MMD and persistent MMD among 1,633 participants, according to antihypertensive medication use. Participants were designated as either (i) an angiotensin-converting enzyme (ACE) inhibitor user (ACEi+), (ii) a user of other antihypertensives not including ACEi (ACEi-), or (iii) nonusers of antihypertensive medications (AHT-). Interactions were explored between antihypertensive use and randomized arm. RESULTS: Interaction terms for MMD (p = .214) and persistent MMD (p = .180) did not reach statistical significance. For MMD, PA displayed marginal effects among ACEi+ (hazard ratio [HR] = 0.76; 95% confidence interval [CI] = 0.57, 1.02) and ACEi- (HR = 0.76; 95% CI = 0.60, 0.97) but not AHT- (HR = 1.19; 95% CI = 0.75, 1.87). For persistent MMD, the effect of PA was greatest among ACEi+ (HR = 0.57; 95% CI = 0.39, 0.84) when compared to ACEi- (HR = 0.76; 95% CI = 0.55, 1.06) or AHT- (HR = 1.18; 95% CI = 0.59, 2.36). CONCLUSIONS: The effects of long-term PA on the incidence of MMD and persistent MMD were similar among three subgroups of older adults stratified by their antihypertensive medication use. However, though statistical interactions did not reach significance, several findings may warrant future study in other cohorts given the post hoc nature of this study.
RCT Entities:
BACKGROUND: This subgroup analysis of the Lifestyle Intervention and Independence for Elders trial evaluates the impact of a long-term physical activity (PA) intervention on rates of major mobility disability (MMD) among older adults according to their antihypertensive medication use. METHODS: Lifestyle Intervention and Independence for Elders study participants were randomized to center-based PA or health education for a median of 2.7 years. Participants were sedentary men and women aged 70-89 years with objectively measured physical limitations. This analysis evaluated rates of MMD and persistent MMD among 1,633 participants, according to antihypertensive medication use. Participants were designated as either (i) an angiotensin-converting enzyme (ACE) inhibitor user (ACEi+), (ii) a user of other antihypertensives not including ACEi (ACEi-), or (iii) nonusers of antihypertensive medications (AHT-). Interactions were explored between antihypertensive use and randomized arm. RESULTS: Interaction terms for MMD (p = .214) and persistent MMD (p = .180) did not reach statistical significance. For MMD, PA displayed marginal effects among ACEi+ (hazard ratio [HR] = 0.76; 95% confidence interval [CI] = 0.57, 1.02) and ACEi- (HR = 0.76; 95% CI = 0.60, 0.97) but not AHT- (HR = 1.19; 95% CI = 0.75, 1.87). For persistent MMD, the effect of PA was greatest among ACEi+ (HR = 0.57; 95% CI = 0.39, 0.84) when compared to ACEi- (HR = 0.76; 95% CI = 0.55, 1.06) or AHT- (HR = 1.18; 95% CI = 0.59, 2.36). CONCLUSIONS: The effects of long-term PA on the incidence of MMD and persistent MMD were similar among three subgroups of older adults stratified by their antihypertensive medication use. However, though statistical interactions did not reach significance, several findings may warrant future study in other cohorts given the post hoc nature of this study.
Authors: B W Penninx; L Ferrucci; S G Leveille; T Rantanen; M Pahor; J M Guralnik Journal: J Gerontol A Biol Sci Med Sci Date: 2000-11 Impact factor: 6.053
Authors: M Di Bari; M Pahor; L V Franse; R I Shorr; J Y Wan; L Ferrucci; G W Somes; W B Applegate Journal: Am J Epidemiol Date: 2001-01-01 Impact factor: 4.897
Authors: Karl D Pendergrass; Nancy T Pirro; Brian M Westwood; Carlos M Ferrario; K Bridget Brosnihan; Mark C Chappell Journal: Am J Physiol Heart Circ Physiol Date: 2008-05-02 Impact factor: 4.733
Authors: Anthony P Marsh; Laura C Lovato; Nancy W Glynn; Kimberly Kennedy; Cynthia Castro; Kathryn Domanchuk; Erica McDavitt; Ruben Rodate; Michael Marsiske; Joanne McGloin; Erik J Groessl; Marco Pahor; Jack M Guralnik Journal: J Gerontol A Biol Sci Med Sci Date: 2013-05-28 Impact factor: 6.053
Authors: Deepa Sumukadas; Margaret Band; Suzanne Miller; Vera Cvoro; Miles Witham; Allan Struthers; Alex McConnachie; Suzanne M Lloyd; Marion McMurdo Journal: J Gerontol A Biol Sci Med Sci Date: 2013-11-07 Impact factor: 6.053
Authors: Jodi D Fitzgerald; Lindsey Johnson; Don G Hire; Walter T Ambrosius; Stephen D Anton; John A Dodson; Anthony P Marsh; Mary M McDermott; Joe R Nocera; Catrine Tudor-Locke; Daniel K White; Veronica Yank; Marco Pahor; Todd M Manini; Thomas W Buford Journal: J Am Heart Assoc Date: 2015-02-18 Impact factor: 5.501
Authors: Carlo Custodero; Sunil K Saini; Myung J Shin; Yun K Jeon; Demetra D Christou; Mary M McDermott; Christiaan Leeuwenburgh; Stephen D Anton; Robert T Mankowski Journal: Exp Gerontol Date: 2020-05-22 Impact factor: 4.032
Authors: Joshua D Brown; Steven M Smith; Elsa S Strotmeyer; Stephen B Kritchevsky; Thomas M Gill; Steven N Blair; Roger A Fielding; Thomas W Buford; Marco Pahor; Todd M Manini Journal: J Gerontol A Biol Sci Med Sci Date: 2020-04-17 Impact factor: 6.053
Authors: Sara A Harper; John R Bassler; Sujitha Peramsetty; Youfeng Yang; Lisa M Roberts; Devin Drummer; Robert T Mankowski; Christiaan Leeuwenburgh; Karina Ricart; Rakesh P Patel; Marcas M Bamman; Stephen D Anton; Byron C Jaeger; Thomas W Buford Journal: Exp Gerontol Date: 2020-10-15 Impact factor: 4.032
Authors: Sara A Harper; Liliana C Baptista; Lisa M Roberts; Sarah J Wherry; Rebecca S Boxer; Kerry L Hildreth; Regina S Seay; P Hunter Allman; Christy S Carter; Inmaculada Aban; Wendy M Kohrt; Thomas W Buford Journal: Front Med (Lausanne) Date: 2020-01-22